Real-time enrollment status for this acute myeloid leukemia, in relapse clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 9:30 PM UTC
| NCT Number | NCT05190471 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia, in Relapse |
| Phase | PHASE1 |
| Target Enrollment | 48 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Bio-Path Holdings, Inc. |
| Last Updated on CT.gov | March 10, 2025 (Mar 10, 2025) |
As of August 30, 2026: Clinical trial NCT05190471 is currently recruiting participants. This phase1 study for acute myeloid leukemia, in relapse is actively seeking new participants at 4 locations across the United States. The study is sponsored by Bio-Path Holdings, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05190471 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05190471 was last updated Mar 10, 2025 (March 10, 2025). HelloStudys verifies this status automatically.